Article
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.
Molecular psychiatry - 1 Nov 2011
Chen X, Lee G, Maher B S, Fanous A H, Chen J, Zhao Z, Guo A, van den Oord E, Sullivan P F, Shi J, Levinson D F, Gejman P V, Sanders A, Duan J, Owen M J, Craddock N J, O'Donovan M C, Blackman J, Lewis D, Kirov G K, Qin W, Schwab S, Wildenauer D, Chowdari K, Nimgaonkar V, Straub R E, Weinberger D R, O'Neill F A, Walsh D, Bronstein M, Darvasi A, Lencz T, Malhotra A K, Rujescu D, Giegling I, Werge T, Hansen T, Ingason A, Nöethen M M, Rietschel M, Cichon S, Djurovic S, Andreassen O A, Cantor R M, Ophoff R, Corvin A, Morris D W, Gill M, Pato C N, Pato M T, Macedo A, Gurling H M D, McQuillin A, Pimm J, Hultman C, Lichtenstein P, Sklar P, Purcell S M, Scolnick E, St Clair D, Blackwood D H R, Kendler K S
Abstract excerpt
We conducted data-mining analyses using the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and molecular genetics of schizophrenia genome-wide association study supported by the genetic association information network (MGS-GAIN) schizophrenia data sets and performed bioinform...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
